Search research articles
Contact Us
Filters
Showing results (61-70 of 143) with videos related to
Page
of 15
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 1, 2025
Dissociable effects of LSD and MDMA on striato-cortical connectivity in healthy subjects
Natalie Ertl, Imran Ashraf, Lisa Azizi, et al.
Frontiers in Psychiatry
|
July 10, 2024
Study protocol for "Psilocybin in patients with fibromyalgia: brain biomarkers of action"
Julia Bornemann, James B Close, Kirran Ahmad, et al.
Psychoneuroendocrinology
|
April 2, 2010
Endogenous plasma estradiol in healthy men is positively correlated with cerebral cortical serotonin 2A receptor binding
Vibe G Frokjaer, David Erritzoe, Anders Juul, et al.
Neuropharmacology
|
May 2, 2012
The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: a pilot [(11)C]Ro15-4513 positron emission tomography study
Maria Andreina Mendez, Jamie Horder, Jim Myers, et al.
The International Journal of Neuropsychopharmacology
|
February 15, 2014
In abstinent MDMA users the cortisol awakening response is off-set but associated with prefrontal serotonin transporter binding as in non-users
Vibe Gedsoe Frokjaer, David Erritzoe, Klaus Kähler Holst, et al.
Bjpsych Open
|
September 6, 2022
Effects of psilocybin versus escitalopram on rumination and thought suppression in depression
Tommaso Barba, Sarah Buehler, Hannes Kettner, et al.
Neuroscience Insights
|
October 10, 2024
Neuroimaging and the Investigation of Drug-Drug Interactions Involving Psychedelics
Matthew B Wall, Rebecca Harding, Natalie Ertl, et al.
Scientific Reports
|
August 22, 2023
Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences
Richard J Zeifman, Hannes Kettner, Broc A Pagni, et al.
Annals of the New York Academy of Sciences
|
July 21, 2025
Perturbing whole-brain models of brain hierarchy: An application for depression following pharmacological treatment
Marcel Socoró-Garrigosa, Yonatan Sanz Perl, Morten L Kringelbach, et al.
Psychiatry Research
|
July 31, 2023
Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis
Otto Simonsson, Per Carlbring, Robin Carhart-Harris, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 143) with videos related to
Sort By:
Page
of 15
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 1, 2025
Dissociable effects of LSD and MDMA on striato-cortical connectivity in healthy subjects
Natalie Ertl, Imran Ashraf, Lisa Azizi, et al.
Frontiers in Psychiatry
|
July 10, 2024
Study protocol for "Psilocybin in patients with fibromyalgia: brain biomarkers of action"
Julia Bornemann, James B Close, Kirran Ahmad, et al.
Psychoneuroendocrinology
|
April 2, 2010
Endogenous plasma estradiol in healthy men is positively correlated with cerebral cortical serotonin 2A receptor binding
Vibe G Frokjaer, David Erritzoe, Anders Juul, et al.
Neuropharmacology
|
May 2, 2012
The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: a pilot [(11)C]Ro15-4513 positron emission tomography study
Maria Andreina Mendez, Jamie Horder, Jim Myers, et al.
The International Journal of Neuropsychopharmacology
|
February 15, 2014
In abstinent MDMA users the cortisol awakening response is off-set but associated with prefrontal serotonin transporter binding as in non-users
Vibe Gedsoe Frokjaer, David Erritzoe, Klaus Kähler Holst, et al.
Bjpsych Open
|
September 6, 2022
Effects of psilocybin versus escitalopram on rumination and thought suppression in depression
Tommaso Barba, Sarah Buehler, Hannes Kettner, et al.
Neuroscience Insights
|
October 10, 2024
Neuroimaging and the Investigation of Drug-Drug Interactions Involving Psychedelics
Matthew B Wall, Rebecca Harding, Natalie Ertl, et al.
Scientific Reports
|
August 22, 2023
Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences
Richard J Zeifman, Hannes Kettner, Broc A Pagni, et al.
Annals of the New York Academy of Sciences
|
July 21, 2025
Perturbing whole-brain models of brain hierarchy: An application for depression following pharmacological treatment
Marcel Socoró-Garrigosa, Yonatan Sanz Perl, Morten L Kringelbach, et al.
Psychiatry Research
|
July 31, 2023
Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis
Otto Simonsson, Per Carlbring, Robin Carhart-Harris, et al.
Page
of 15